Back to Markets
ACAchieve Life Sciences Inc

Achieve Life Sciences Inc

ACHVNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$5.24

-0.060000 (-1.13%)

As of 05/29/26 EDT · USD

Compare
Low: $2.00Current: $5.24High: $6.15

Key Statistics

Open

$5.35

Day High

$5.49

Day Low

$5.24

Prev. Close

$5.30

VolumeShares traded today.

996.55K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$537.93M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-4.71

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$6.15

52W LowLowest price over the past 52 weeks.

$2.00

50D MAAverage closing price over the last 50 trading days.

$4.20

200D MAAverage closing price over the last 200 trading days.

$4.15

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+13.9%

1M

+26.3%

6M

+14.2%

YTD

+5.4%

1Y

+46.4%

About

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.

achievelifesciences.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade ACHV

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.